150 views | 9 years ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses why he chooses Illumina technology for NIPT, PGS, and PGD. Learn more about how next-generation sequencing (NGS)...
149 views | 8 years ago
Since the late 1800s, the field of immuno-oncology has been exploring the immune system and the development, progression, and treatment of cancer. With over a century's worth of discoveries as the guide,...
149 views | 1 decade ago
Hear about Illumina's collaborative approach to developing TruSight content sets.
146 views | 5 years ago
Introducing the HiSeq™ Expert Video Tips series. This 5-part series includes usage tips, troubleshooting advice, best practices, and other common customer questions regarding the HiSeq instrument. This...
145 views | 5 years ago
Hear professors from the University of Queensland share their goals of advancing polygenic risk scores in order to move them into the clinic to better treat complex diseases like immune disorders, cancer,...
143 views | 5 years ago
Dr Eric Topol, director of the Scripps Translational Science Institute, which is playing an important role in the “All of Us” project, discusses the importance of the project, the kind of data being...
140 views | 8 years ago
As genetic testing becomes more complex, the need for education continues to grow. Our webinar series, “Noninvasive Prenatal Testing: Background, Science, and Clinical Implementation,” was developed...
136 views | 5 years ago
In the final chapter of the PRS series, learn more about future uses for polygenic risk scores, from stratifying populations and targeting high-risk individuals to early intervention and preventative...